ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.

15 Jul 2025

ECO Animal Health - FY Results - Investor Presentation video - 14 July 2025

David Hallas (CEO) and Chris Wilks (CFO) of ECO Animal Health conducted an Investor Presentation covering their Full Year Results for the period to 31st March 2025.

Management discussed the good growth in the US and Brazil, and the measures taken to protect themselves from tariffs and generics. The team also discussed the progression of the R&D pipeline, detailing time to market in their six key projects.

Management provided a detailed overview of key financial performance and answered a range of questions submitted by viewers.

The full video is available to watch, divided into chapters as below:
0:00:00 Beginning
0:00:18 Executive Summary
0:12:16 Financial Highlights
0:26:50 R&D Growth Engine
0:32:09 Outlook & Summary
0:35:20 Questions & Answers

Return to ECO Animal Health

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 3rd Floor, 80 Cheapside, London, EC2V 6EE

Website design & development by Breckenridge